Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.
| Trades 4 | Longs Won 1/4 25% | Profit Factor 0.02 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $34,054.38 |
| Average Win $1,744.31 | Best Trade (Sep 10) $1,744.31 | Sharpe Ratio -11.88 |
| Average Loss -$27,780.08 | Worst Trade (Jan 02) -$71,121.95 | Z-Score 2 (95.45%) |
| Commissions $0 | Avg. Trade Length 3m 1w 1d | Expectancy -$20,398.98 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | - | - | - | - | - | - | - | - | - | - |
| Consecutive Losing Trades | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
IMNM Immunome, Inc. | 1,026.44 | $25,732.84 | $18,404.06 | - | -$7,328.78 | -28.48% | -0.334% |